Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||||
Founding Date | Founding Date 2006 | Founding Date 1929 | Founding Date 1985 | Founding Date 1904 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Chapel Hill, US HQ | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 2903% decrease | Employees 5,358 | Employees 9,067 | Employees 7,5692% decrease |
Valuation ($) | Valuation ($) 188.9 m | Valuation ($) 10.2 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $96.4m (FY, 2018) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) $7.9b (FY, 2020) |
Cost of goods | Cost of goods $41.1m (FY, 2018) | Cost of goods €659.1m (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $55.4m (FY, 2018) | Gross profit €3.3b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit $4.5b (FY, 2020) |
Net income | Net income ($157.2m) (FY, 2018) | Net income €445.1m (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income N/A |
Operating ⚠ | ||||
Trademark Applications | Trademark Applications N/A | Trademark Applications N/A | Trademark Applications 3 (Sep, 2023) | Trademark Applications 1 (Dec, 2020) |
Trademarks | Trademarks N/A | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks 4 (Dec, 2020) |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company